Thursday 24 September 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
1
Average plausibility
62%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
RegionAllGlobalAfricaNorth AmericaSouth AmericaAsia-PacificEuropeMiddle East
TopicAllPoliticsConflict & SecurityBusinessScienceHealth
01HealthMiddle East

Saudi Arabia announces $1.3 billion in biotech deals after a Riyadh summit

Plans include the Gulf's largest vaccine plant as the kingdom pursues a 2040 biotech-hub goal.

Saudi Arabia announced $1.3 billion in biotechnology deals after a Riyadh summit, Semafor reported, including a $130 million vaccine facility billed as the Gulf's largest. Eli Lilly, Johnson & Johnson and Novo Nordisk already have regional headquarters in Riyadh.

What holds up

  • ✓Named Saudi health officials discussed the push with Semafor.
  • ✓Major drugmakers have regional headquarters in Riyadh.

What doesn't yet

  • ?The $1.3 billion total has not been itemised.
  • ?Becoming a global biotech hub by 2040 is an ambition, not an outcome.

Ask before you share

  • →How much is committed capital versus non-binding memoranda?
  • →What regulatory and talent gaps could hold it back?
  • →Will it improve medicine access for the wider region?

Sources & original reporting

  1. [1]Semafor · Published 23 Sept 2026 · semafor.com